TABLE 4.

Multivariate analysis—risk factors for mortality: Propensity matched pairs post conversion to everolimus.

Variable	Hazard ratio	p-value
EVE	1.10 (0.73–1.66)	0.642
Estimated GFR at time of starting EVE	1.00 (0.99–1.01)	0.938
FVC % predicted at time of starting EVE	0.99 (0.98–1.00)	0.023
No CLAD	REF
BOS a	4.30 (2.16–8.58)	<0.0001
RAS a	2.36 (1.23–4.53)	0.010
Mycophenolate	0.62 (0.40–0.98)	0.043

Abbreviations: BOS, bronchiolitis obliterans syndrome; CLAD, chronic lung allograft dysfunction; EVE, everolimus; FVC, forced vital capacity; GFR, glomerular filtrate rate; RAS, restrictive allograft syndrome.

^a Diagnosis of BOS or RAS pre or post starting EVE.